Article
Low activity of dapsone N-hydroxylation as a susceptibility risk factor in aggressive bladder cancer.
Pharmacogenetics - 1 Aug 1994
Fleming C M, Persad R, Kaisary A, Smith P, Adedoyin A, Porter J, Wilkinson G R, Branch R A
Abstract excerpt
N-arylamines involved in the pathogenesis of bladder cancer, require metabolic activation via N-hydroxylation. The efficiency of in vivo N-hydroxylation of dapsone, a non-carcinogenic arylamine, may, therefore, provide a host susceptibility measure of risk of developing bladder cancer. To investigate this possibility, the dapsone recovery ratio, a phenotypic measure of the efficiency of dapsone hydroxylation, has...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
